- CNBC•2 days ago
Jim Cramer provides his opinion on various caller favorite stocks, including this horrendous stock in the dog house.
- Business Wire•16 days ago
Synergy Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies, today reported its financial results and business update for the three months ended June 30, 2016.
- Business Wire•24 days ago
Synergy Pharmaceuticals Inc. today announced Marino Garcia, the company’s EVP and Chief Strategy Officer, will present a corporate update at the Canaccord Genuity 36th Annual Growth Conference on Thursday, August 11, 2016 at 10:00 a.m.
Synergy Pharmaceuticals, Inc. (SGYP)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||4.65 x 200|
|Ask||4.98 x 500|
|Day's Range||4.36 - 5.05|
|52wk Range||2.50 - 7.72|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-3.80|
|Avg Vol (3m)||2,922,776|
|Dividend & Yield||N/A (N/A)|